US · OACC
Oaktree Acquisition Corp. III Life Sciences
- Sector
- Financial Services · Shell Companies
- Headquarters
- Los Angeles, CA 90071
- Website
- oaktreeacquisitioncorp.com
Price · as of 2024-12-31
$10.60
Market cap 262.23M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | — | — |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | $10.10 |
AI valuation
Our deep-learning model estimates Oaktree Acquisition Corp. III Life Sciences's (OACC) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- —
- Current price
- $10.60
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| OACC | Oaktree Acquisition Corp.… | $10.60 | 262.23M | — | — | — | — | 93235.44 | 1.32 | — | — | — | 1.32 | 0.00% | — | — | — | — | — | 0.00 | — | 2.14 | 1.87 | — | — | — | — | 0.00% | 0.00 | — | 0.00% | 0.00% | 0.00% | -351267.06 | -1356817.29 | — | 19.19 |
| CGCT | Cartesian Growth Corporat… | $10.13 | 279.59M | — | — | — | — | — | — | — | — | — | — | 0.00% | — | — | — | — | — | -2.36 | — | 0.01 | 0.00 | — | — | — | — | — | 0.00 | — | — | 0.00% | — | — | — | — | — |
| FACT | FACT II Acquisition Corp | $10.34 | 251.48M | +155% | -61% | — | — | -4.42 | -2.56 | 2.29 | -5.63 | — | -1.87 | 36.33% | -63.00% | -51.91% | 64.76% | -626.45% | -58.87% | -1.53 | 4.22 | 1.20 | 0.82 | -1.99 | -7927.00% | 2411.00% | -710.00% | -21.92% | -0.69 | -499.84% | 0.00% | 0.00% | 0.00% | -5.63 | -7.05 | 3.55 | -4.05 |
| MBAV | M3-Brigade Acquisition V … | $10.54 | 378.78M | — | — | — | — | 70.00 | 1.30 | — | -805.05 | — | 1.30 | 0.00% | — | — | — | — | — | 0.00 | — | 1.47 | 1.13 | 1.81 | — | — | — | -0.14% | -0.69 | — | 0.00% | 0.00% | 0.00% | -805.05 | -725.85 | — | 15.47 |
| MLAC | Mountain Lake Acquisition… | $10.43 | 323.25M | — | — | — | — | 30.18 | 1.04 | — | -191.22 | 1.69 | 1.04 | 0.00% | — | — | 3.56% | -0.56% | 3.49% | 0.00 | — | 1.91 | 1.55 | 0.35 | 178811.00% | — | 48224.00% | -0.37% | -3.19 | -0.40% | 0.00% | 0.00% | 0.00% | -191.22 | -268.07 | — | 116.05 |
| RAC | Rithm Acquisition Corp. | $10.38 | 245.59M | — | — | — | — | 55.84 | 1.33 | — | 55.74 | — | 1.33 | 0.00% | — | — | — | — | — | 0.00 | — | 15.69 | 11.46 | -0.10 | — | — | — | -0.22% | -13.13 | — | 0.00% | 0.00% | 0.00% | -556.49 | -451.37 | — | 22.50 |
| SOUL | Soulpower Acquisition Cor… | $10.25 | 262.61M | — | — | — | — | — | — | — | — | — | — | 0.00% | — | — | — | — | — | -1.87 | — | 1.01 | 0.59 | -1.08 | — | — | — | — | -2.85 | — | — | 0.00% | — | — | — | — | — |
About Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
- CEO
- Zaid Pardesi
- Employees
- 3
- Beta
- 0.14
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $10.60) − 1 = — (DCF, example).